Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun 24:6:28514.
doi: 10.1038/srep28514.

Mendelian Randomisation study of the influence of eGFR on coronary heart disease

Collaborators, Affiliations

Mendelian Randomisation study of the influence of eGFR on coronary heart disease

Pimphen Charoen et al. Sci Rep. .

Abstract

Impaired kidney function, as measured by reduced estimated glomerular filtration rate (eGFR), has been associated with increased risk of coronary heart disease (CHD) in observational studies, but it is unclear whether this association is causal or the result of confounding or reverse causation. In this study we applied Mendelian randomisation analysis using 17 genetic variants previously associated with eGFR to investigate the causal role of kidney function on CHD. We used 13,145 participants from the UCL-LSHTM-Edinburgh-Bristol (UCLEB) Consortium and 194,427 participants from the Coronary ARtery DIsease Genome-wide Replication and Meta-analysis plus Coronary Artery Disease (CARDIoGRAMplusC4D) consortium. We observed significant association of an unweighted gene score with CHD risk (odds ratio = 0.983 per additional eGFR-increasing allele, 95% CI = 0.970-0.996, p = 0.008). However, using weights calculated from UCLEB, the gene score was not associated with disease risk (p = 0.11). These conflicting results could be explained by a single SNP, rs653178, which was not associated with eGFR in the UCLEB sample, but has known pleiotropic effects that prevent us from drawing a causal conclusion. The observational association between low eGFR and increased CHD risk was not explained by potential confounders, and there was no evidence of reverse causation, therefore leaving the remaining unexplained association as an open question.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Association between baseline eGFR and CHD in quintiles (left), and comparing low and moderate eGFR to normal/high eGFR (right), in the UCLEB data (1515 cases, 5247 controls).
Figure 2
Figure 2. Benjamini-Hochberg adjusted P-values for CHD-trait and eGFR-trait (N range of CHD-trait = 139-13145, and N range of eGFR-trait = 138-6764).
Horizontal line shows adjusted P = 0.05.28 traits significantly associated with both CHD and eGFR on dotted vertical lines are identified as potential confounding factors: age, alcohol, body mass index, ECG Cornell product, cotinine, CRP, D-Dimer, Eosinophils, factor VIII, Factor IX, FEV1, fibrinogen, FVC, HDL, IL-6, Neutrophil, percentage body fat, peak expiratory flow rate, NT-proBNP, ECG QTc, ECG QT interval, sex, total serum protein concentration, Triglyceride, tPa, von Willebrand factor, waist circumference, weight. Abbreviations used in the figure are defined in S3 Table.
Figure 3
Figure 3. Benjamini-Hochberg adjusted P-values for unweighted and weighted gene score-trait associations (N range = 139-15609).
Only kidney function traits (eGFR, creatinine, and serum urea concentration) are shown to be significantly associated with either gene score (dotted vertical lines). See S5 Table for further details of summary statistics.

References

    1. Chronic Kidney Disease Prognosis Consortium et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375, 2073–2081, doi: 10.1016/S0140-6736(10)60674-5 (2010). - DOI - PMC - PubMed
    1. van der Velde M. et al. Screening for albuminuria identifies individuals at increased renal risk. J Am Soc Nephrol 20, 852–862, doi: 10.1681/ASN.2008060655 (2009). - DOI - PMC - PubMed
    1. Cai Q., Mukku V. K. & Ahmad M. Coronary artery disease in patients with chronic kidney disease: a clinical update. Curr Cardiol Rev 9, 331–339 (2013). - PMC - PubMed
    1. Matsushita K. et al. Subclinical Atherosclerosis Measures for Cardiovascular Prediction in CKD. J Am Soc Nephrol 26, 439–447, doi: 10.1681/ASN.2014020173 (2015). - DOI - PMC - PubMed
    1. Shlipak M. G. et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation 107, 87–92 (2003). - PubMed